Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy

MLA

Sadayoshi Ito, et al. “Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy.” Hypertension Research : Official Journal of the Japanese Society of Hypertension, vol. 31, no. 6, Aug. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d074cff955150aa89d2eb853766574e6&authtype=sso&custid=ns315887.

APA

Sadayoshi Ito, Kazuhiro Nako, Susumu Ogawa, & Takefumi Mori. (2008). Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. Hypertension Research : Official Journal of the Japanese Society of Hypertension, 31(6).

Chicago

Sadayoshi Ito, Kazuhiro Nako, Susumu Ogawa, and Takefumi Mori. 2008. “Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy.” Hypertension Research : Official Journal of the Japanese Society of Hypertension 31 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d074cff955150aa89d2eb853766574e6&authtype=sso&custid=ns315887.